<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-124977</identifier>
<setSpec>0211-139X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Diarrhea associated with Clostridium difficile in the elderly: new perspectives</dc:title>
<dc:description xml:lang="en">Infection due to Clostridium difficile is currently the main cause of hospital acquired gastrointestinal disease. Its prevalence in the elderly population is higher due to there being many associated risk factors in this age group, such as comorbidity, frequent exposure to the healthcare or residential home setting, immunosenescence, greater consumption of antibiotics, and antiacids. The diagnostic techniques have notably improved in the last few years, which could also account for an increase in its diagnosis. The new expert consensus recommendations propose stratifying the clinical situation of the patient in order to choose the treatment option. Therapeutic options have recently been included in the new Clinical Guidelines, such as flidaxomicin or fecal transplants, with encouraging results, particularly for the control of frequent recurrences (AU)</dc:description>
<dc:creator>Pareja-Sierra, Teresa</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La infección por Clostridium difficile es actualmente la principal causa de enfermedad gastrointestinal de origen nosocomial. Su prevalencia en la población anciana es superior por reunirse en este grupo etario gran cantidad de factores de riesgo como son comorbilidad, frecuente exposición al medio sanitario o residencial, inmunosenescencia y mayor consumo de antibióticos y antiácidos. En los últimos años, las técnicas diagnósticas han mejorado notablemente, lo que podría implicar un incremento de diagnósticos. Las nuevas pautas de consenso de expertos proponen la estratificación de la situación clínica del paciente en el momento del diagnóstico para la elección del tratamiento óptimo. Recientemente se han incluido en las guías clínicas nuevas opciones terapéuticas como la flidaxomicina o el trasplante de materia fecal con resultados alentadores, sobre todo para el control de las frecuentes recurrencias (AU)</dc:description>
<dc:source>Rev. esp. geriatr. gerontol. (Ed. impr.);49(4): 188-193, jul.-ago. 2014.</dc:source>
<dc:identifier>ibc-124977</dc:identifier>
<dc:title xml:lang="es">Diarrea asociada a Clostridium difficile en el anciano: nuevas perspectivas</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d23504^s22073</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d28477^s22012</dc:subject>
<dc:subject>^d8985^s22073</dc:subject>
<dc:subject>^d28890^s22001</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d3994^s22080</dc:subject>
<dc:subject>^d24572</dc:subject>
<dc:subject>^d3994^s22054</dc:subject>
<dc:subject>^d3994^s22032</dc:subject>
<dc:subject>^d38340</dc:subject>
<dc:subject>^d3994^s22047</dc:subject>
<dc:subject>^d911^s22073</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d33510^s22073</dc:subject>
<dc:type>article</dc:type>
<dc:date>201408</dc:date>
</metadata>
</record>
</ibecs-document>
